1. Home
  2. ACRV vs MLEC Comparison

ACRV vs MLEC Comparison

Compare ACRV & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • MLEC
  • Stock Information
  • Founded
  • ACRV 2018
  • MLEC 2008
  • Country
  • ACRV United States
  • MLEC United Kingdom
  • Employees
  • ACRV N/A
  • MLEC N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • MLEC Blank Checks
  • Sector
  • ACRV Health Care
  • MLEC Finance
  • Exchange
  • ACRV Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • ACRV 41.7M
  • MLEC 36.0M
  • IPO Year
  • ACRV 2022
  • MLEC N/A
  • Fundamental
  • Price
  • ACRV $1.33
  • MLEC $1.53
  • Analyst Decision
  • ACRV Buy
  • MLEC
  • Analyst Count
  • ACRV 7
  • MLEC 0
  • Target Price
  • ACRV $17.40
  • MLEC N/A
  • AVG Volume (30 Days)
  • ACRV 213.8K
  • MLEC 94.4K
  • Earning Date
  • ACRV 08-13-2025
  • MLEC 10-01-2025
  • Dividend Yield
  • ACRV N/A
  • MLEC N/A
  • EPS Growth
  • ACRV N/A
  • MLEC N/A
  • EPS
  • ACRV N/A
  • MLEC N/A
  • Revenue
  • ACRV N/A
  • MLEC N/A
  • Revenue This Year
  • ACRV N/A
  • MLEC $20.42
  • Revenue Next Year
  • ACRV $1,037.93
  • MLEC $30.00
  • P/E Ratio
  • ACRV N/A
  • MLEC N/A
  • Revenue Growth
  • ACRV N/A
  • MLEC 170.36
  • 52 Week Low
  • ACRV $1.05
  • MLEC $1.52
  • 52 Week High
  • ACRV $10.16
  • MLEC $10.47
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 51.00
  • MLEC 12.35
  • Support Level
  • ACRV $1.27
  • MLEC $2.31
  • Resistance Level
  • ACRV $1.42
  • MLEC $2.57
  • Average True Range (ATR)
  • ACRV 0.08
  • MLEC 0.28
  • MACD
  • ACRV 0.00
  • MLEC -0.00
  • Stochastic Oscillator
  • ACRV 55.32
  • MLEC 0.00

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: